Report Categories
View AllRecent Articles
View All
Daily Market Overview Sp 500 Nasdaq Edge Higher Dow Dips Slightly In Mixed Trade 20260403 1
Vnda Stock Analysis Vanda Pharmaceuticals Inc. Holds 7 Level After 0.99 Pct Daily Dip 20260403
VOC Energy VOC Earnings Outlook Key Metrics for Q3 2024
Winnebago Industries WGO Q1 2026 Earnings Surprise EPS 027 Up Significant
Inflation Pressures Broaden Beyond Energy Consumers Face Rising Costs Across Multiple Sectors
Otter Tail OTTR Q1 2026 Earnings Why the Beat Matters
Talos Energy TALO Climbs 212 Resistance at 1742 in Focus 20260519
Cerebras Systems Soars in Trading Debut Reaching 80 Billion Market Valuation
Exxon XOM Q1 2026 Earnings Beat Revenue NA EPS 116
Global Markets Cautious as World Leaders Await TrumpXi Summit Outcomes
Thailand Slashes VisaFree Stay to 30 Days for UK and Over 90 Countries Tourism Sector Adjusts
Fathom Holdings FTHM Q4 2025 Earnings Miss Breaking Down the Numbers
Kevin Warsh Confirmed as Next Federal Reserve Chair in Historic Vote
Tepid Demand at US Treasury Auction Signals Investor Caution Amid Iran Tensions
Qualcomms Rally Signals Growing Investor Confidence in AI Device Boom
UK Government Proposes VAT Reduction for Theme Parks and Childrens Meals to Ease CostofLiving Burden
Analysts Offer Mixed Views on News Corporation Stock Amid Digital Transformation
HDFC Secs Vinay Rajani Highlights NearTerm Potential for LT Finance and Sandur Manganese
Morrisons to Close 100 Stores Amid Rising Cost Pressures from Government Policies
ECVT Q1 2026 Earnings Earnings Surge Past Estimates with 975 Surprise
UTI Q1 2026 Earnings EPS Misses Estimates but Stock Surges on Operational Momentum
OneSpan Inc Q1 2026 Earnings EPS Beats Estimates by 1335 Amid Solid Execution
BRX Q1 2026 Earnings Strong EPS Surprise of 635 Despite Slight Stock Decline
BFH Q1 2026 Earnings Beats Estimates with EPS Surprise of 3383
Atea Pharmaceuticals AVIR Gains 425 as Stock Tests Key Resistance Level
FGMCU Experiences Minor Decline as SPAC Unit Nears Key Support Zone
COPT Defense Properties Edges Higher Amid Steady Demand for DefenseOriented Real Estate CDP
Iterum Therapeutics ITRM Holds at 003 as MicroCap Biotech Waits for Catalysts